Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion type Assertion NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_head.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion description "[In the absence of anthracyclines, trastuzumab and paclitaxel induced a high rate of pCR, exploiting the synergy between the immunomodulating properties of these drugs and the retained immunological proficiency of patients with HER2-overexpressing BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_provenance.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion evidence source_evidence_literature NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_provenance.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion SIO_000772 25512030 NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_provenance.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion wasDerivedFrom befree-2016 NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_provenance.
- NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_assertion wasGeneratedBy ECO_0000203 NP1248399.RAIlmXuMAswluhuLPP4iOisptzuSH45DOTH2aHp159V40130_provenance.